# Mucin-degrading gut bacteria: context-dependent roles in intestinal homeostasis and disease

**Authors:** Eunike Tiffany, Kyoung Su Kim, Panida Sittipo, Dong-Woo Lee, Yun Kyung Lee

PMC · DOI: 10.1080/19490976.2026.2614054 · Gut Microbes · 2026-01-23

## TL;DR

This paper reviews how mucin-degrading gut bacteria influence gut health and disease through their interactions with the host and other microbes.

## Contribution

The paper provides a comprehensive review of the dual roles of mucin-degrading bacteria in gut homeostasis and disease.

## Key findings

- Mucin-degrading bacteria modulate gut barrier function and immune responses through mucin degradation.
- Their roles are context-dependent, affecting both gastrointestinal and systemic health.
- These bacteria offer potential for microbiota-targeted therapies to restore gut homeostasis.

## Abstract

Akkermansia muciniphila, Bacteroides thetaiotaomicron, Mediterraneibacter (formerly Ruminococcus) gnavus, and other mucin-degrading (MD) bacteria play pivotal roles in shaping gut microbial ecosystems, maintaining gut barrier function, and mediating host–microbiota crosstalk. These bacteria influence intestinal homeostasis by modulating epithelial cell differentiation, immune responses, and gut microbiota composition through mucin degradation and the production of bioactive metabolites. Their abundance and functional activities fluctuate dynamically in response to dietary components, host immunity, and environmental factors, resulting in context-dependent effects on gastrointestinal and systemic health. This review summarizes current insights into the ecology and metabolic capabilities of MD bacteria, highlighting their dual roles in metabolic disorders, inflammatory diseases, infection susceptibility, and neuroimmune conditions. Understanding the ecological niches and molecular interactions of MD bacteria offers promising approaches for microbiota-targeted therapies aimed at restoring gut and systemic homeostasis.

## Linked entities

- **Species:** Akkermansia muciniphila (taxon 239935), Bacteroides thetaiotaomicron (taxon 818), Mediterraneibacter gnavus (taxon 33038)

## Full-text entities

- **Genes:** Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Mucin [NCBI Gene 100508689], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Gpr35 (G protein-coupled receptor 35) [NCBI Gene 64095] {aka KPG_007}
- **Diseases:** diabetes mellitus (MESH:D003920), insulin resistance (MESH:D007333), gastrointestinal and extra-intestinal disorders (MESH:D005767), glucose intolerance (MESH:D018149), Extra-intestinal diseases (MESH:D007410), AD (MESH:D000544), Neurological disorder (MESH:D009461), ankle swelling (MESH:D016512), atopic dermatitis (MESH:D003876), food allergy (MESH:D005512), enteric infections (MESH:D004751), M. (MESH:C566367), lupus nephritis (MESH:D008181), immune-metabolic dysfunction (MESH:D007154), weight loss (MESH:D015431), Dysbiosis (MESH:D064806), MS (MESH:D009103), Allergy (MESH:D004342), CRC (MESH:D015179), Enteroendocrine cell deficiency (MESH:D002292), PD (MESH:D010300), gut and systemic diseases (MESH:D034721), IBS (MESH:D043183), liver steatosis (MESH:D005234), tumorigenesis (MESH:D063646), diarrhea (MESH:D003967), colonic inflammation (MESH:D007249), Metabolic diseases (MESH:D008659), fat mass gain (MESH:C536030), autoimmune and (MESH:D001327), obesity (MESH:D009765), dermatitis (MESH:D003872), MD (MESH:D055959), autoimmune, metabolic, neurological, and dermatological diseases (MESH:D020274), Citrobacter rodentium infection (MESH:D007239), atopic (MESH:C566404), CD (MESH:D003424), colitis (MESH:D003092), liver injury (MESH:D017093), neuroinflammation (MESH:D000090862), neurodegeneration (MESH:D019636), type 2 diabetes (MESH:D003924), gammadelta T cell-deficient (MESH:D016399), rheumatoid arthritis (MESH:D001172), UC (MESH:D003093), tumor (MESH:D009369), MD bacteria (MESH:C000719206), SLE (MESH:D008180), IBD (MESH:D015212), Salmonella Typhimurium infection (MESH:D012480), EAE (MESH:D004681), diabetic nephropathy (MESH:D003928)
- **Chemicals:** TNBS (MESH:D014302), acetate (MESH:D000085), 2,7-anhydro-Neu5Ac (MESH:C045712), carbon (MESH:D002244), arabinoxylans (MESH:C085118), monosaccharides (MESH:D009005), succinate (MESH:D019802), indoles (MESH:D007211), tryptamine (MESH:C030820), serine (MESH:D012694), carbohydrate (MESH:D002241), threonine (MESH:D013912), gamma-amino butyric acid (MESH:D005680), bile acid (MESH:D001647), malto-oligosaccharides (MESH:C021705), CO2 (MESH:D002245), ornithine (MESH:D009952), serotonin (MESH:D012701), L-fucose (MESH:D005643), phenethylamine (MESH:C029261), citrulline (MESH:D002956), LPS (MESH:D008070), hydrogen peroxide (MESH:D006861), glycan (MESH:D011134), N-acetylglucosamine-6-sulfate (MESH:C033137), fumarate (MESH:D005650), aromatic amino acid (MESH:D024322), lysophosphatidylcholine (MESH:D008244), nitrogen (MESH:D009584), dextrins (MESH:D003912), inulin (MESH:D007444), vitamin B12 (MESH:D014805), lipid (MESH:D008055), butyrate (MESH:D002087), ornithine lipids (MESH:C051524), Amino acid (MESH:D000596), propionate (MESH:D011422), glycine ursodeoxycholic acid (MESH:C024033), sugars (MESH:D000073893), propionic acid (MESH:C029658), DSS (MESH:D016264), glucose (MESH:D005947), pseudovitamin B12 (MESH:C005602), tryptophan (MESH:D014364), sphingolipid (MESH:D013107), sialic acid (MESH:D019158), 2-fucosyllactose (MESH:C031420), ursodeoxycholic acid (MESH:D014580), indole (MESH:C030374), A. muciniphila (-), methionine (MESH:D008715), AOM (MESH:D001397), beta-glucan (MESH:D047071), galactose (MESH:D005690), pectin (MESH:D010368), SCFA (MESH:D005232), fat (MESH:D005223)
- **Species:** Bacteroides caccae (species) [taxon 47678], Bacteroides acidifaciens (species) [taxon 85831], Escherichia coli (E. coli, species) [taxon 562], Bacteroides thetaiotaomicron (species) [taxon 818], Bifidobacterium bifidum (species) [taxon 1681], Campylobacter jejuni (species) [taxon 197], Bifidobacterium longum (species) [taxon 216816], Bacteroides fragilis (species) [taxon 817], Mediterraneibacter (genus) [taxon 2316020], Mus musculus (house mouse, species) [taxon 10090], Citrobacter rodentium (species) [taxon 67825], Bacteroides salyersiae (species) [taxon 291644], Homo sapiens (human, species) [taxon 9606], Faecalibacterium prausnitzii (species) [taxon 853], Clostridia (class) [taxon 186801], Akkermansia muciniphila (species) [taxon 239935], Lactobacillus (genus) [taxon 1578], Phocaeicola vulgatus (species) [taxon 821], Mediterraneibacter gnavus (species) [taxon 33038], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Bacteroides ovatus (species) [taxon 28116], Bacteroides sp. (species) [taxon 29523], Bacteroides xylanisolvens (species) [taxon 371601], Barnesiella intestinihominis (species) [taxon 487174], Phocaeicola dorei (species) [taxon 357276], Anaerobutyricum hallii (species) [taxon 39488], Parabacteroides goldsteinii (species) [taxon 328812]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), HT29-MTX — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_6834)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12834151/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12834151/full.md

## References

199 references — full list in the complete paper: https://tomesphere.com/paper/PMC12834151/full.md

---
Source: https://tomesphere.com/paper/PMC12834151